Favourable renal survival in paediatric microscopic polyangiitis: Efficacy of a novel treatment algorithm

Nephrology Dialysis Transplantation

Volumn 30, Issue , 2015, Pages i113-i118

  Basu, Biswanath ^a   Mahapatra, T K S ^a   Mondal, Nirmal ^a  

^a NRS MEDICAL COLLEGE   (India)

Author keywords

Microscopic polyangiitis; paediatrics; rituximab

Indexed keywords

COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; STEROID; ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; MYCOPHENOLATE MOFETIL; MYCOPHENOLIC ACID; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG RESPONSE; DRUG SAFETY; DYSPEPSIA; DYSPNEA; FEMALE; FLATULENCE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; MALE; MICROSCOPIC POLYANGIITIS; NEUTROPENIA; PLASMAPHERESIS; PNEUMOCYSTOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RELAPSE; REMISSION; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SCHOOL CHILD; SINGLE DRUG DOSE; SURVIVAL RATE; TREATMENT FAILURE; UPPER RESPIRATORY TRACT INFECTION; ALGORITHM; ANALOGS AND DERIVATIVES; DRUG COMBINATION; IMMUNOLOGY; KIDNEY DISEASES; MORTALITY; PATHOLOGY; TREATMENT OUTCOME;

ALGORITHMS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; MALE; MICROSCOPIC POLYANGIITIS; MYCOPHENOLIC ACID; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84926674787     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv016     Document Type: Article

References (21)

1. Jennette JC, Falk RJ, Bacon PA et al. 2012 Revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013; 65: 1-11
2. Arulkumaran N, Jawad S, Smith SW et al. Long-term outcome of paediat-ric patients with ANCA vasculitis. Pediatr Rheumatol 2011; 9: 12-18
3. Corral-Gudino L, Borao-Cengotita-Bengoa M, Pino-Montes J et al. Overall survival, renal survival and relapse in patients with microscopic polyangiitis: a systematic review of current evidence. Rheumatology 2011; 50: 1414-1423
4. Schwartz GJ, Munoz A, Schneider MF et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20: 629-637
5. Anonymous. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555-576
6. Dolezalova P, Price-Kuehne FE, Özen S et al. Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). Ann Rheum Dis 2013; 72: 1628-1633
7. Watts RA, Mooney J, Skinner J et al. The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangii-tis. Rheumatology 2012; 51: 926-931
8. Fujimoto S, Watts RA, Kobayashi S et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology 2011; 50: 1916-1920
9. Eleftheriou D, Melo M, Marks SD et al. Biologic therapy in primary systemic vasculitis of the young. Rheumatology 2009; 48: 978-986
10. Sun L, Wang H, Jiang X et al. Clinical and pathological features of microscopic polyangiitis in 20 children. J Rheumatol 2014; 41: 1712-1719
11. Sellier-Leclerc AL, Macher MA, Loirat C et al. Rituximab efficiency in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 2010; 25: 1109-1115
12. Huang CK, Fang HC, Chou KJ et al. Clinical features of microscopic poly-angiitis: a cohort study in a Southern Taiwan Medical Center. Acta Ne-phrologica 2012; 26: 198-205
13. Yamato K, Ishii T, Kawamura T. Microscopic polyangiitis in a girl with severe anemia and no respiratory symptoms. Pediatr Int 2012; 54: 541-543
14. Chen M, Yu F, Zhang Y et al. Clinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre. Postgrad Med J 2005; 81: 723-727
15. Guillevin L, Durand-Gasselin B, Cevallos R et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999; 42: 421-430
16. Hu WX, Liu ZH, Liu CB et al. Prognosis of microscopic polangyiitis with renal involvement: report of 60 Chinese patients. Chin Med J 2005; 118: 2089-2092
17. Bakkaloglu A, Ozen S, Baskin E et al. The significance of antineutrophil cytoplasmic antibody in microscopic polyangitis and classic polyarteritis nodosa. Arch Dis Child 2001; 85: 427-430
18. Peco-Antic A, Bonaci-Nikolic B, Basta-Jovanovic G et al. Childhood microscopic polyangiitis associated with mpo-anca. Pediatr Nephrol 2006; 21: 46-53
19. Fujieda M, Hattori M, Kurayama H et al. Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glom-erulonephritis associated with propylthiouracil treatment. J Am Soc Nephrol 2002; 13: 437-445
20. Lionaki S, Blyth ER, Hogan SL et al. Classification of antineutrophil cyto-plasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum 2012; 64: 3452-3462
21. Akcan-Arikan A, Zappitelli M, Loftis LL et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 2007; 71: 1028-1035